The South Korean pharmaceutical industry is highly fragmented, with almost all the domestic pharmaceutical companies having a strong portfolio of generic products rather than expensive, branded drugs. An increase in insurance coverage, an ageing population and favorable government initiatives are expected to drive future growth in the pharmaceutical industry in South Korea. Improved intellectual property rights, changing demographics and government support have contributed towards making the South Korean pharmaceutical industry attractive for MNCs.
To Find more :
Visit : http://www.researchonglobalmarkets.com/south-korea-pharmaceutical-market-outlook-2013.html
Mail : support@researchonglobalmarkets.com
Call : +1 866 325 7446 / +91 22 4098 7600
